Two novel fibrinogen variants found in patients with pulmonary embolism and their families

Journal of Thrombosis and Haemostasis

Volumn 1, Issue 6, 2003, Pages 1251-1257

  Hanss, M M L ^a,b   Ffrench, P O ^a   Mornex, J F ^a   Chabuet, M ^c   Biot, F ^a   De Mazancourt, P ^d   Dechavanne, M ^a  

^a LOUIS PRADEL HOSPITAL   (France)

^b EDOUARD HERRIOT HOSPITAL   (France)

^c Centre d'Examens de Santé   (France)

^d RAYMOND POINCARÉ HOSPITAL   (France)

Author keywords

Fibrinogen variant; Gel electrophoresis; Pulmonary embolism; Venous thrombosis

Indexed keywords

FIBRINOGEN;

ADULT; ARTICLE; CASE CONTROL STUDY; CASE REPORT; FAMILY HEALTH; FEMALE; FRAMESHIFT MUTATION; GENETIC VARIABILITY; GENETICS; HUMAN; LUNG EMBOLISM; MALE; NUCLEOTIDE SEQUENCE; POINT MUTATION; PREGNANCY; STOP CODON; THROMBOSIS;

ADULT; BASE SEQUENCE; CASE-CONTROL STUDIES; CODON, TERMINATOR; DNA MUTATIONAL ANALYSIS; FAMILY HEALTH; FEMALE; FIBRINOGEN; FRAMESHIFT MUTATION; HUMANS; MALE; POINT MUTATION; PREGNANCY; PULMONARY EMBOLISM; THROMBOSIS; VARIATION (GENETICS);

EID: 2142751535     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1046/j.1538-7836.2003.00244.x     Document Type: Article

References (38)

1. Blombäck B. Fibrinogen and fibrin-proteins with complex roles in haemostasis and thrombosis. Thromb Res 1996; 83: 1-75.
2. Mosesson M. Fibrinogen functions and fibrin assembly. Fibrinol Proteol 2000; 14: 182-6.
3. Roberts HR, Stinchcombe TE, Gabriel DA. The dysfibrinogenaemias. Br J Haematol 2001; 114: 249-57.
4. Ebert RF. Index of Variant Human Fibrinogen. Boca Raton: CRC Press, 1994.
5. Haverkate F, Samama M. Familial dysfibrinogenemia and thrombophilia: report on a study of the SSC subcommittee on fibrinogen. Thromb Haemost 1995; 73: 151-61.
6. Mosesson MW. Dysfibrinogenemia and thrombosis. Sem Thromb Hemost 1999; 3: 311-9.
7. Matsuda M, Sugo T, Yoshida N, Terukina S, Yamazumi K, Niwa K, Maekawa H. Structure and functions of fibrinogen: insights from dysfibrinogens. Thromb Haemost 1999; 82: 283-90.
8. Mann KG. Biochemistry and physiology of blood coagulation. Thromb Haemost 1999; 82: 165-74.
9. Doolittle RF. The structure and evolution of vertebrate fibrinogen. Ann NY Acad Sci 1983; 408: 13-27.
10. Rosendaal FR. Venous thrombosis: a multicausal disease. Lancet 1999; 353: 1167-73.
11. Seligsohn U, Lubetsky A. Genetic susceptibility to venous thrombosis. N Engl J Med 2001; 16: 1231-22.
12. Mazoyer E, Ripoll L, Gueguen R, Bessie're C, Thomas S, Bal dit Sollier C, Drouet L. Environmental and genetic influences on fibrinogen level differently evidenced according to the technique of fibrinogen measurement: FITE-NAT multicenter study. Thromb Haemost 2001; Suppl.: P2197(Abstract).
13. Matsuda M, Baba M, Morimoto K, Nakamikawa C. Fibrinogen Tokyo II: an abnormal fibrinogen with an impaired polymerization site on the aligned DD domain of fibrin molecules. J Clin Invest 1983; 72: 1034-41.
14. Kazal LA, Amsel S, Miller OP, Tocantins LM. The preparation and some properties of fibrinogen precipitated from human plasma by glycine. Proc Soc Exp Biol Med 1963; 113: 989-94.
15. Sambrook J, Fritsch EF, Maniatis T. In: Nolan C, Ford N, Ferguson M (eds) Molecular Cloning, Vol. 2. New York: Cold Spring Harbour Laboratory Press, 1989: 9.16-9.
16. Egeberg O. Inherited fibrinogen abnormality causing thrombophilia. Thromb Diath Haemorrh 1967; 17: 176-87.
17. Lachmann HJ, Booth DR, Booth SE, Bybee A, Gilbertson JA, Gillmore JD, Pepys MB, Hawkins PN. Misdiagnosis of hereditary amyloidosis as AL (primary) amyloidosis. N Engl J Med 2002; 346: 1786-91.
18. Hanss M, Biot F. A database for human fibrinogen variants. Ann NY Acad Sci 2001; 936: 89-90.
19. Lefkowitz JB, DeBoom T, Weller A, Clarke S, Lavrinets D. Fibrinogen Longmont: a dysfibrinogenemia that causes prolonged clot based test results only when using an optical detection method. Am J Hematol 2000; 63: 149-55.
20. Liu CY, Koehn JA, Morgan FJ. Characterization of fibrinogen New York I. A dysfunctional fibrinogen with a deletion of B b (9-72) corresponding exactly to exon 2 of the gene. J Biol Chem 1985; 260: 4390-6.
21. Rosenberg JB, Newman PJ, Mosesson MW, Guillin MC, Amrani DL. Paris I dysfibrinogenemia: a point mutation in intron 8 results in insertion of a 15 amino acid sequence in the fibrinogen gamma-chain. Thromb Haemost 1993; 69: 217-20.
22. Ebert RF, Bell WR. Fibrinogen Baltimore III: congenital dysfibrinogenemia with a shortened gamma-subunit. Thromb Res 1988; 51: 251-8.
23. Kaudewitz H, Henschen A, Soria J, Soria C. Fibrinogen Pontoise-a genetically abnormal fibrinogen with defective fibrin polymerization but normal fibrinopeptide release. In: Lane DA, Henschen A, Jasani MK, eds. Fibrinogen-Fibrin Formation and Fibrinolysis. Berlin: Walter de Gruyter, 1986: 91-6.
24. Koopman J, Haverkate F, Grimbergen J, Lord ST, Mosesson MW, DiOrio JP, Siebenlist KS, Legrand C, Soria J, Soria C, Caen JP. Molecular basis for fibrinogen Dusard (Aa 554Arg!Cys) and its association with abnormal fibrin polymerization and thrombophilia. J Clin Invest 1993; 91: 1637-43.
25. Tsurupa G, Tsonev L, Medved L. Structural organization of the fibrin (ogen) alpha C-domain. Biochemistry 2002; 41: 6449-59.
26. Eisenhaber F, Imperiale F, Argos P, Froemmel C. Prediction of secondary structure content of proteins from their amino acid composition alone. I. New analytic vector decomposition methods. Proteins: Struct Funct Design 1996; 25: 169-79.
27. Murakawa M, Okamura T, Kamura T, Shibuya T, Harada M, Niho Y. Diversity of primary structures of the carboxy-terminal regions of mammalian fibrinogen Aa-chains. Thromb Haemost 1993; 69: 351-60.
28. Tsurupa G, Medved L. Identification and characterization of novel tPAand plasminogen-binding sites within fibrin(ogen) alpha C-domains. Biochemistry 2001; 40: 801-8.
29. Doolittle RF, Watt KW, Cottrell BA, Strong DD, Riley M. The amino acid sequence of the alpha-chain of human fibrinogen. Nature 1979; 280: 464-8.
30. Yoshida N, Terukina S, Okuma M, Moroi M, Aoki N, Matsuda M. Characterization of an apparently lower molecular weight gamma chain variant in fibrinogen Kyoto I. The replacement of gamma asparagine 308 by lysine which causes accelerated cleavage of fragment D1 by plasmin and the generation of a new plasmin cleavage site. J Biol Chem 1988; 263: 13848-56.
31. Koopman J, Haverkate F, Grimbergen J, Engesser L, Novakova I, Kerst AF, Lord ST. Abnormal fibrinogens Ijmuiden (Bβ Arg14→Cys) and Nijmegen (Bβ Arg44→Cys) form disulfide-linked fibrinogen-albumin complexes. Proc Natl Acad Sci USA 1992; 89: 3478-82.
32. Wada Y, Lord ST. A correlation between thrombotic disease and a specific fibrinogen abnormality (Aα 554 Arg→Cys) in two unrelated kindred, Dusart and Chapel Hill III. Blood 1994; 84: 3709-14.
33. Steinmann C, Bögli C, Jungo M, Lämmle B, Heinemann G,Wermuth B, Redaelli R, Baudo F, Furlan M. A new substitution, γ358 Ser→Cys, in fibrinogen Milano VII causes defective fibrin polymerization. Blood 1994; 84: 1874-80.
34. Neerman-Arbez M. The molecular basis of inherited afibrinogenaemia. Thromb Haemost 2001; 86: 154-63.
35. Duga S, Asselta R, Santagostino E, Zeinali S, Simonic T, Malcovati M, Mannucci PM, Tenchini ML. Missense mutations in the human β fibrinogen gene cause congenital afibrinogenemia by impairing fibrinogen secretion. Blood 2000; 95: 1336-41.
36. Asselta R, Spena S, Duga S, Peyvandi F, Malcovati M, Mannucci PM, Tenchini ML. Analysis of Iranian patients allowed the identification of the first truncating mutation in the fibrinogen Bβ-chain gene causing afibrinogenemia. Haematologica 2002; 87: 855-9.
37. Spena S, Duga S, Asselta R, Malcovati M, Peyvandi F, Tenchini ML. Congenital afibrinogenemia: first identification of splicing mutations in the fibrinogen Bβ-chain gene causing activation of cryptic splice sites. Blood 2002; 100: 4478-84.
38. Zhang JZ, Redman CM. Identification of Bβ chain domains involved in human fibrinogen assembly. J Biol Chem 1992; 267: 21727-32.